Cargando…

Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy

PURPOSE: To assess the relationship between patient-reported quality-of-life (QOL) outcomes and provider-assessed adverse events (AEs) during head-and-neck (H&N) radiotherapy (RT). METHODS: Sixty-five patients undergoing H&N RT prospectively completed 12-domain linear analogue self-assessmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niska, Joshua R., Thorpe, Cameron S., Halyard, Michele Y., Tan, Angelina D., Atherton, Pamela J., Dueck, Amylou C., Patel, Samir H., Sloan, Jeff A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364694/ https://www.ncbi.nlm.nih.gov/pubmed/32677021 http://dx.doi.org/10.1186/s41687-020-00227-4

Ejemplares similares

Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Lee, Minji K., et al.
Publicado: (2020)

Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Lee, Minji K., et al.
Publicado: (2021)

Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Lee, Minji K., et al.
Publicado: (2023)

Choosing wisely after publication of level I evidence in breast cancer radiotherapy
por: Niska, Joshua R, et al.
Publicado: (2018)

The Efficacy and Adverse Events in Patients with Head and Neck Cancer Following Radiotherapy Combined with S-1 Therapy: A Meta-Analysis
por: Shih, Hung-Sheng, et al.
Publicado: (2021)

Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia
por: Tremblay, Douglas, et al.
Publicado: (2021)

A novel approach of longitudinal adverse event evaluation in oncology clinical trials: the Toxicity over Time (ToxT) analysis of clinical trials N9741 and 979254 (Alliance)
por: Thanarajasingam, Gita, et al.
Publicado: (2016)

Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events
por: Atkinson, Thomas M., et al.
Publicado: (2018)

Exploratory study of the association of volumetric modulated arc therapy (VMAT) plan robustness with local failure in head and neck cancer
por: Liu, Wei, et al.
Publicado: (2017)

Adaptive radiotherapy for head and neck cancer
por: Morgan, Howard E., et al.
Publicado: (2020)

Oral complications of radiotherapy in the head and neck
por: Jham, Bruno Correia, et al.
Publicado: (2015)

Above and Beyond Age: Prediction of Major Postoperative Adverse Events in Head and Neck Surgery
por: Mascarella, Marco A., et al.
Publicado: (2021)

Population‐level evidence of survival benefits of patient‐reported outcome symptom monitoring software systems in routine cancer care
por: Basch, Ethan, et al.
Publicado: (2020)

Score equivalence of paper-, tablet-, and interactive voice response system-based versions of PROMIS, PRO-CTCAE, and numerical rating scales among cancer patients
por: Lee, Minji K., et al.
Publicado: (2021)

Identifying meaningful change on PROMIS short forms in cancer patients: a comparison of item response theory and classic test theory frameworks
por: Lee, Minji K., et al.
Publicado: (2022)

Technical Advances and Pitfalls in Head and Neck Radiotherapy
por: Parvathaneni, Upendra, et al.
Publicado: (2012)

Defining the target for radiotherapy of head and neck cancer
por: Nuyts, S.
Publicado: (2007)

Current strategies in radiotherapy of head and neck cancer
por: Pütz, M., et al.
Publicado: (2012)

Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
por: Runnels, Juliana, et al.
Publicado: (2023)

Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes
por: Sprangers, Mirjam A. G., et al.
Publicado: (2010)

Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)
por: Major-Elechi, Brittny T., et al.
Publicado: (2018)

Statin Use and Risk of Vascular Events Among Cancer Patients After Radiotherapy to the Thorax, Head, and Neck
por: Boulet, Jacinthe, et al.
Publicado: (2019)

Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose
por: Niska, Joshua R., et al.
Publicado: (2021)

Impact of xerostomia on the quality of life of patients submitted to head and neck radiotherapy
por: do Nascimento, Michele Lopes, et al.
Publicado: (2019)

Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic
por: Curtis, Kelly K., et al.
Publicado: (2016)

PET/CT in Radiotherapy Planning for Head and Neck Cancer
por: Newbold, Katie, et al.
Publicado: (2012)

Utilization of custom electron bolus in head and neck radiotherapy
por: Kudchadker, R. J., et al.
Publicado: (2003)

Role of radiotherapy in the treatment of metastatic head and neck cancer
por: Ordoñez, Rafael, et al.
Publicado: (2019)

Radiomics and Machine Learning for Radiotherapy in Head and Neck Cancers
por: Giraud, Paul, et al.
Publicado: (2019)

Head and neck radiotherapy - A risk factor for anaesthesia?
por: Jain, Deepshikha, et al.
Publicado: (2020)

Impact of delays in radiotherapy of head and neck cancer on outcome
por: Žumer, Barbara, et al.
Publicado: (2020)

Oral management strategies for radiotherapy of head and neck cancer
por: Kawashita, Yumiko, et al.
Publicado: (2020)

Magnetic Resonance Guided Radiotherapy for Head and Neck Cancers
por: Gharzai, Laila A., et al.
Publicado: (2022)

FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer
por: Dolezel, Martin, et al.
Publicado: (2022)

Artificial intelligence to predict outcomes of head and neck radiotherapy
por: Bang, Chulmin, et al.
Publicado: (2023)

Radiotherapy and Systemic Therapies: Focus on Head and Neck Cancer
por: De Felice, Francesca, et al.
Publicado: (2023)

Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
por: Mazza, Gina L., et al.
Publicado: (2021)

Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck
por: Apisarnthanarax, Smith, et al.
Publicado: (2011)

Persistent Post-radiotherapy Pain and Locoregional Recurrence in Head and Neck Cancer-Is There a Hidden Link?
por: Srivastava, Preety, et al.
Publicado: (2015)

Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
por: Mazza, Gina L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67uauniau2pct82hibqp1gae9b